Christopher Brett

Christopher Brett is an experienced leader in clinical trial strategy and operations, currently serving as Vice President at Bristol Myers Squibb since November 2019. Previously, Christopher held the position of Vice President of Clinical Operations at Celgene from March 2015 to November 2019, where responsibilities included global trial management and clinical quality management. Prior to that, at Merck, Christopher worked from June 1996 to March 2015 in various roles, including Director of Clinical Research and Lead of Global Trial Management & Monitoring for the Cardiovascular and Atherosclerosis franchise. Christopher began a clinical research career at Memorial Sloan-Kettering Cancer Center focusing on prostate cancer treatment options. Educationally, Christopher holds a Bachelor of Arts degree from the University of Delaware.